Oragenics, Inc. (OGEN)
0.7544
-0.07
(-8.18%)
USD |
NYAM |
Dec 30, 16:00
0.7511
0.00 (0.00%)
After-Hours: 20:00
Oragenics EPS Diluted (Quarterly): -1.965 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| NanoViricides, Inc. | -0.1045 |
| Actinium Pharmaceuticals, Inc. | -0.1645 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.067M |
| Total Expenses (Quarterly) | 3.067M |
| Enterprise Value | -10.39M |
| Earnings Yield | -1.75K% |
| Normalized Earnings Yield | -1747.61 |